Mepact - direct healthcare professional communication (DHPC)

mifamurtide

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Mepact 4mg (mifamurtide): Potential for filter leakage or malfunction

Key facts

• Medicine name:
  Mepact
• Active substance:
  mifamurtide
• Therapeutic area (MeSH):
  Osteosarcoma
• DHPC type:
  Quality defect
• Human ATC codes:
  L03AX15
• Dissemination date:
  25/02/2020